Results 151 to 160 of about 78,261 (320)

Estimating the association and timing of occurrence between obesity and related comorbidity outcomes in a real‐world setting: A cohort study in the United States

open access: yesClinical Obesity, EarlyView.
Estimating the Association and Timing of Occurrence between Obesity and Related Comorbidity Outcomes in a Real‐World Setting: A Cohort Study in the United States. An observational, retrospective cohort study of adults with available body mass index (BMI) data during the period 2010–2019 in a large United States claims‐linked electronic health records ...
Firas Dabbous   +9 more
wiley   +1 more source

RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer [PDF]

open access: hybrid, 2001
Taro Oshikiri   +11 more
openalex   +1 more source

Autoimmunity in MASLD: Focus on autoantibodies, anti‐apolipoprotein A1 IgG and G protein‐coupled receptors

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
This review outlines the potential role of anti‐GPCR autoantibodies in MASLD/MASH, given their involvement in a wide range of diseases and their possible contribution to MASLD/MASH pathophysiology. We also focused on anti‐ApoA1 autoantibodies, sharing functional features with anti‐GPCR autoantibodies and have been shown to promote liver steatosis in ...
Sabrina Pagano   +3 more
wiley   +1 more source

Focal Spot, Winter 2006/2007 [PDF]

open access: yes, 2007
https://digitalcommons.wustl.edu/focal_spot_archives/1104/thumbnail ...

core   +1 more source

A case of cancer in adenoma of the gallbladder in a patient with gastric cancer.

open access: bronze, 1986
Yutaka Ozeki   +5 more
openalex   +2 more sources

PI5P4K inhibitors: promising opportunities and challenges

open access: yesThe FEBS Journal, EarlyView.
Developing inhibitors is like climbing a steep, challenging mountain. PI5P4K inhibitors hold significant promise for the treatment of cancer, immune disorders, and neurological diseases. However, the path to success is fraught with hurdles, and researchers are therefore required to apply their expertise to overcome critical “checkpoints.” While some ...
Koh Takeuchi   +16 more
wiley   +1 more source

Central blood volume in cirrhosis [PDF]

open access: yes, 1993
Bendtsen, Flemming   +2 more
core   +1 more source

Focal Spot, Spring 1990 [PDF]

open access: yes, 1990
https://digitalcommons.wustl.edu/focal_spot_archives/1054/thumbnail ...

core   +1 more source

Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study

open access: bronze, 1993
B.G. Taal   +7 more
openalex   +1 more source

Comparison of 5‐Fluorouracil/Leucovorin and Capecitabine as Adjuvant Therapies in Biliary Tract Cancer

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background The prognosis of biliary tract cancer (BTC) is poor, and recurrence rates remain high even after curative resection. This study aimed to compare the efficacy and safety of capecitabine and 5‐fluorouracil/leucovorin (FL) as adjuvant treatments following curative resection in patients with BTC.
Tae Seung Lee   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy